Different expression patterns of carbonic anhydrase IX in oral lichen planus and leukoplakia.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Acta odontológica latinoamericana

• Publication date

  2018-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 30383070
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The use of CA-IX as a diagnostic method for oral leukoplakia

  2015cited by this paper
• The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review.

  2014cited by this paper
• Expression of cancer‐related carbonic anhydrases IX and XII in normal skin and skin neoplasms

  2014cited by this paper
• Expression of CA IX in dysplasia adjacent to surgical resection margins of oral squamous cell carcinoma

  2014cited by this paper
• Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study.

  2014cited by this paper
• Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients.

  2014cited by this paper
• Increased expression of carbonic anhydrase IX in oral submucous fibrosis and oral squamous cell carcinoma

  2014cited by this paper
• Carbonic anhydrase type IX expression in lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.

  2013cited by this paper
• Oral lichen planus: focus on etiopathogenesis.

  2013cited by this paper
• Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics

  2012cited by this paper
• pH control mechanisms of tumor survival and growth

  2011cited by this paper
• Altered expression of mRNA for HIF-1alpha and its target genes RTP801 and VEGF in patients with oral lichen planus.

  2010cited by this paper
• Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1α, GLUT1, and CAIX

  2010cited by this paper
• Carbonic anhydrases: novel therapeutic applications for inhibitors and activators

  2008cited by this paper
• Nomenclature and classification of potentially malignant disorders of the oral mucosa.

  2007cited by this paper
• Association of progressive structural changes in the bronchial epithelium with subepithelial fibrous remodeling: A potential role for hypoxia

  2007cited by this paper
• Targeting tumor-associated carbonic anhydrase IX in cancer therapy.

  2006cited by this paper
• Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer

  2003cited by this paper
• Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer.

  2001cited by this paper
• Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density.

  2001cited by this paper
• Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma.

  1999cited by this paper
• MN/CA9 gene expression as a potential biomarker in renal cell carcinoma

  1999cited by this paper
• The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase–polymerase chain reaction assay for MN/CA9

  1999cited by this paper
• Immunohistochemistry of Carbonic Anhydrase Isozyme IX (MN/CA IX) in Human Gut Reveals Polarized Expression in the Epithelial Cells with the Highest Proliferative Capacity

  1998cited by this paper
• MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker.

  1997cited by this paper
• Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix.

  1996cited by this paper
• A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN.

  1996cited by this paper
• Hypoxia and Mitochondrial Inhibitors Regulate Expression of Glucose Transporter-1 via Distinct Cis-acting Sequences (*)

  1995cited by this paper
• Expression of MaTu‐MN protein in human tumor cultures and in clinical specimens

  1993cited by this paper
• Definition of leukoplakia and related lesions: an aid to studies on oral precancer.

  1978cited by this paper

• A Molecular Hypothesis on Malignant Transformation of Oral Lichen Planus: A Systematic Review and Meta-Analysis of Cancer Hallmarks Expression in This Oral Potentially Malignant Disorder

  2024cites this paper
• CA9 transcriptional expression determines prognosis and tumour grade in tongue squamous cell carcinoma patients

  2020cites this paper
• Genetic Basis of Oral Health Conditions

  2019cites this paper
• Genetic Basis of Lichen Planus and Oral Cancer

  2019cites this paper